| Primary |
| Diabetes Insipidus |
41.2% |
| Enuresis |
9.2% |
| Infantile Spasms |
6.1% |
| Hypopituitarism |
5.3% |
| Platelet Disorder |
4.6% |
| Von Willebrand's Disease |
4.6% |
| Product Used For Unknown Indication |
3.8% |
| Tonic Convulsion |
3.8% |
| Convulsion |
3.1% |
| Nocturia |
2.3% |
| Pain |
2.3% |
| Bladder Disorder |
1.5% |
| Haemorrhage |
1.5% |
| Hormone Replacement Therapy |
1.5% |
| Hypernatraemia |
1.5% |
| Lipids Increased |
1.5% |
| Polydipsia |
1.5% |
| Polyuria |
1.5% |
| Prophylaxis |
1.5% |
| Pyrexia |
1.5% |
|
| Hyponatraemia |
9.9% |
| Myocardial Infarction |
9.9% |
| Tremor |
9.9% |
| Vomiting |
8.5% |
| Convulsion |
5.6% |
| Overdose |
5.6% |
| Restlessness |
5.6% |
| Drug Ineffective |
4.2% |
| Hospitalisation |
4.2% |
| Hypernatraemia |
4.2% |
| Medication Error |
4.2% |
| Stevens-johnson Syndrome |
4.2% |
| Visual Disturbance |
4.2% |
| Accidental Overdose |
2.8% |
| Depression |
2.8% |
| Haemorrhage |
2.8% |
| Incorrect Product Storage |
2.8% |
| Nausea |
2.8% |
| Poisoning |
2.8% |
| Pollakiuria |
2.8% |
|
| Secondary |
| Diabetes Insipidus |
18.8% |
| Infantile Spasms |
14.0% |
| Tonic Convulsion |
9.2% |
| Convulsion |
7.0% |
| Pain |
6.6% |
| Toothache |
5.2% |
| Pyrexia |
4.4% |
| Bladder Disorder |
3.9% |
| Product Used For Unknown Indication |
3.9% |
| Enuresis |
3.5% |
| Multiple Sclerosis |
3.1% |
| Drug Therapy |
2.6% |
| Hypernatraemia |
2.6% |
| Constipation |
2.2% |
| Hypertension |
2.2% |
| Nausea |
2.2% |
| Osteoporosis |
2.2% |
| Pruritus |
2.2% |
| Rash |
2.2% |
| Vomiting |
2.2% |
|
| Medication Error |
17.2% |
| Vomiting |
12.5% |
| Hyponatraemia |
9.4% |
| Visual Disturbance |
9.4% |
| Tremor |
6.3% |
| Convulsion |
4.7% |
| Drug Hypersensitivity |
4.7% |
| Incorrect Product Storage |
4.7% |
| Pancytopenia |
4.7% |
| Blood Sodium Decreased |
3.1% |
| Depression |
3.1% |
| Hypoaesthesia |
3.1% |
| Pain |
3.1% |
| Pulmonary Oedema |
3.1% |
| Wrong Drug Administered |
3.1% |
| Accidental Overdose |
1.6% |
| Complex Partial Seizures |
1.6% |
| Cough |
1.6% |
| Drug Ineffective |
1.6% |
| Hospitalisation |
1.6% |
|
| Concomitant |
| Product Used For Unknown Indication |
20.8% |
| Drug Use For Unknown Indication |
17.8% |
| Hypopituitarism |
8.7% |
| Diabetes Insipidus |
6.0% |
| Growth Hormone Deficiency |
5.7% |
| Pain Management |
5.2% |
| Pyrexia |
4.3% |
| Muscle Spasms |
4.2% |
| Infection Prophylaxis |
3.4% |
| Pain |
2.5% |
| Gastrooesophageal Reflux Disease |
2.4% |
| Nausea |
2.4% |
| Diabetes Mellitus |
2.2% |
| Vomiting |
2.2% |
| Hypothyroidism |
2.1% |
| Insomnia |
2.1% |
| Cerumen Impaction |
2.1% |
| Lung Infection |
2.1% |
| Adrenal Insufficiency |
1.9% |
| Coagulopathy |
1.9% |
|
| Electrolyte Imbalance |
16.0% |
| Vomiting |
8.0% |
| Death |
6.4% |
| Hypernatraemia |
5.6% |
| Weight Increased |
5.6% |
| Craniopharyngioma |
4.8% |
| Ventricular Septal Defect |
4.8% |
| Weight Decreased |
4.8% |
| Anhedonia |
4.0% |
| Brain Neoplasm |
4.0% |
| Condition Aggravated |
4.0% |
| Drug Ineffective |
4.0% |
| Injury |
4.0% |
| Neoplasm Recurrence |
4.0% |
| Pulmonary Embolism |
4.0% |
| Cerebrovascular Accident |
3.2% |
| Cns Germinoma |
3.2% |
| Electrocardiogram Qt Prolonged |
3.2% |
| Myalgia |
3.2% |
| Nausea |
3.2% |
|
| Interacting |
|
|
